Fund 1 Investments LLC Has $1.72 Million Stock Holdings in Bath & Body Works, Inc. $BBWI

Fund 1 Investments LLC trimmed its stake in shares of Bath & Body Works, Inc. (NYSE:BBWIFree Report) by 94.1% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 74,404 shares of the company’s stock after selling 1,195,775 shares during the quarter. Fund 1 Investments LLC’s holdings in Bath & Body Works were worth $1,721,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors also recently made changes to their positions in the stock. Caisse de depot et placement du Quebec bought a new stake in Bath & Body Works in the second quarter valued at approximately $3,719,000. Man Group plc bought a new position in Bath & Body Works during the 2nd quarter worth approximately $22,670,000. Jupiter Topco LLC acquired a new position in shares of Bath & Body Works in the 2nd quarter worth approximately $1,830,000. Hsbc Holdings PLC bought a new stake in shares of Bath & Body Works in the 2nd quarter valued at $13,651,000. Finally, Primecap Management Co. CA bought a new stake in shares of Bath & Body Works in the 2nd quarter valued at $7,110,000. 95.14% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of equities analysts recently weighed in on the stock. Jefferies Financial Group lifted their target price on shares of Bath & Body Works from $22.00 to $23.00 and gave the stock a “hold” rating in a research note on Tuesday, July 28th. Wells Fargo & Company upped their price target on shares of Bath & Body Works from $25.00 to $26.00 and gave the company an “overweight” rating in a research report on Tuesday, June 23rd. Telsey Advisory Group decreased their price target on Bath & Body Works from $25.00 to $22.00 and set a “market perform” rating for the company in a report on Thursday, May 28th. Raymond James Financial reissued a “market perform” rating on shares of Bath & Body Works in a research note on Wednesday, May 27th. Finally, Morgan Stanley restated an “equal weight” rating and set a $22.00 target price on shares of Bath & Body Works in a research report on Monday, July 6th. Four research analysts have rated the stock with a Buy rating, thirteen have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus target price of $22.57.

View Our Latest Research Report on Bath & Body Works

Bath & Body Works News Summary

Here are the key news stories impacting Bath & Body Works this week:

  • Positive Sentiment: Bath & Body Works reported second-quarter adjusted EPS of $0.62, well above the $0.24 analyst consensus, while revenue of $1.51 billion slightly exceeded expectations. Bath & Body Works Q2 Earnings and Revenues Surpass Estimates
  • Positive Sentiment: Management raised fiscal 2026 adjusted EPS guidance to $2.60-$2.80, above its previous range of $2.40-$2.65 and ahead of the roughly $2.56 consensus. The company also reiterated revenue expectations of approximately $7.5-$7.6 billion. Bath & Body Works Raises Earnings Outlook on Higher Profit
  • Positive Sentiment: Digital demand and direct-channel sales growth are offsetting weaker physical-store traffic. Management also highlighted ongoing transformation initiatives, including planned cost savings, stronger cash flow and potential balance-sheet improvement that could support future shareholder returns. Bath & Body Works lifts annual profit forecast
  • Neutral Sentiment: The earnings call and bullish commentary frame BBWI as a discounted turnaround opportunity, but investors will likely require sustained sales growth and execution before assigning a higher valuation.
  • Negative Sentiment: Second-quarter net sales declined 2.3% year over year, and third-quarter adjusted EPS guidance of only $0.07-$0.12 is substantially below the approximately $0.27 consensus. The outlook reflects continued near-term pressure from store traffic and seasonality. Bath & Body Works falls despite earnings beat
  • Negative Sentiment: Heavy put-option activity ahead of the report signaled elevated bearish hedging and helps explain the stock’s volatility despite the earnings beat.

Bath & Body Works Trading Up 7.6%

BBWI opened at $18.92 on Thursday. Bath & Body Works, Inc. has a 1-year low of $14.27 and a 1-year high of $32.32. The company has a market cap of $3.81 billion, a P/E ratio of 5.31, a price-to-earnings-growth ratio of 1.73 and a beta of 1.38. The company has a fifty day moving average price of $20.36 and a two-hundred day moving average price of $20.01.

Bath & Body Works (NYSE:BBWIGet Free Report) last released its quarterly earnings data on Wednesday, August 26th. The company reported $0.62 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.24 by $0.38. The company had revenue of $1.51 billion for the quarter, compared to analysts’ expectations of $1.50 billion. Bath & Body Works had a net margin of 10.03% and a negative return on equity of 45.34%. The business’s revenue was down 2.3% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.30 EPS. Bath & Body Works has set its Q3 2026 guidance at 0.070-0.120 EPS and its FY 2026 guidance at 2.600-2.800 EPS. On average, research analysts forecast that Bath & Body Works, Inc. will post 2.63 EPS for the current fiscal year.

Bath & Body Works Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, September 4th. Investors of record on Friday, August 21st will be paid a dividend of $0.20 per share. This represents a $0.80 dividend on an annualized basis and a yield of 4.2%. The ex-dividend date of this dividend is Friday, August 21st. Bath & Body Works’s dividend payout ratio is 22.47%.

Bath & Body Works Profile

(Free Report)

Bath & Body Works, Inc is a leading specialty retailer focused on personal care, home fragrance and complementary products. Through its flagship Bath & Body Works brand, the company offers a diverse assortment of shower gels, lotions, fragrance mists, candles and home fragrance items. Its product portfolio also includes the White Barn Candle Co range of premium scented candles and diffusers. Bath & Body Works serves consumers through a combination of brick-and-mortar stores and e-commerce platforms, delivering seasonal collections, limited-edition releases and signature scent lines.

Founded in 1990 as part of Limited Brands (now L Brands), Bath & Body Works opened its first store in New Albany, Ohio, and quickly expanded across the United States.

Featured Stories

Want to see what other hedge funds are holding BBWI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Bath & Body Works, Inc. (NYSE:BBWIFree Report).

Institutional Ownership by Quarter for Bath & Body Works (NYSE:BBWI)

Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.com's FREE daily email newsletter.